Second PharmSci@India 2011 Symposium will be held on 3rd and 4th September, 2011 at National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad. PharmSci@India is a student-initiated joint symposium set up in 2010 by The American Association of Pharmaceutical Scientists-National University of Singapore Student Chapter (ANSC). Our purpose is to foster relationship and to create awareness of possible collaboration between universities from these 2 countries. First PharmSci@India symposium received an exceptional inauguration at the Bombay College of Pharmacy campus, Kalina, Mumbai, in year 2010 and it served as an excellent platform for knowledge exchanges among the students from several universities in India and NUS.
Second PharmSci@India symposium at National University of Pharmaceutical Education and Research (NIPER), Hyderabad would also promote professional/scientific interactions between research students and experts from academics/industries of India and Singapore with an aim to be informed of the state-of-affairs and latest developments in pharmaceutical research. This sympoisum will comprise of enlightening talks from eminent speakers, keynote lectures and oral/poster presentations by research students.
Call for papers
Abstract submission is now open! Please use the template provided here and email us at aaps@niperhyd.ac.in (participants from India) or nusaaps@gmail.com (participants from Singapore) before 20 August 2011.
Registration
All participants are required to register for the conference using the registration form provided.
Registration fees applicable are:
a) Students / Scholars / Faculty - Rs. 500/-
b) Otherwise - Rs. 1,000/-
The registration fee can be paid by Demand Draft drawn in favour of “NIPER, Hyderabad” payable at Hyderabad, INDIA.
Participants are advised to send their demand draft and printed copy of registration form to
Registrar,
National Institute of Pharmaceutical Education and Research (NIPER),
Balanagar,Hyderabad, India - 500 037 by 20th August, 2011.
0 Comments:
Post a Comment